NCT07018453View on ClinicalTrials.gov

A Study Comparing SHR-3167 and Insulin Degludec in Type 2 Diabetic Subjects Treated With Basal Insulin With or Without Oral Antidiabetic Drugs

PHASE2Not yet recruitingINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

June 30, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

May 31, 2026

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

SHR-3167

SHR-3167 Injection.

DRUG

Insulin Degludec

Insulin Degludec Injection.

Trial Locations (2)

200032

Zhongshan Hospital Affiliated to Fudan University, Shanghai

400000

The First Affiliated Hospital of Chongqing Medical University, Chongqing

All Listed Sponsors
lead

Jiangsu HengRui Medicine Co., Ltd.

INDUSTRY